AbbVie
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
ABBV News
AbbVie Inc. (NYSE:ABBV) on Monday shared topline results from the Phase 2 ELATE trial evaluating onabotulinumtoxinA (BOTOX) compared to placebo for upper limb e...
AbbVie (NYSE:ABBV) announced that its mid-stage study of Botox (onabotulinumtoxinA) for treating essential tremor in the upper limbs achieved its main goal. Th...
AbbVie (ABBV) announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA compared to placebo for t...
Analyst ratings
61%
of 31 ratingsMore ABBV News
AbbVie recently submitted a Biologics License Application to the FDA for pivekimab sunirine, an investigational therapy targeting rare blood cancers, and began...
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model ba...
Home Investing Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV, GD, RGR) Investing Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV...
In a regulatory filing, the company stated, “Reported GAAP earnings and adjusted non-GAAP earnings for the third quarter of 2025 are expected to include acquire...
St. Louis Financial Planners Asset Management, LLC initiated a new stake in AbbVie (ABBV -0.85%), acquiring 14,630 shares for an estimated $3.39 million in Q3 2...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powe...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock po...